The FDA's drug approval process is a critical aspect of the pharmaceutical industry, as it ensures that new drugs and medical treatments meet strict safety and efficacy standards before they can be made available to the public.

Several of the podcast episodes discuss the FDA's role in this process, including the potential implications of the Supreme Court's mifepristone decision on the broader FDA approval process A Presidential Polling Update, And SCOTUS's Mifepristone Decision and the plaintiffs' claims about the FDA's approval of mifepristone being flawed or improperly rushed How The Mifepristone Case Reached SCOTUS.

Additionally, the podcast episode The Psychedelic Mind with Rick Doblin discusses the FDA's regulations around clinical trials and the drug approval process for psychedelics like MDMA, which Doblin's organization MAPS has been studying to treat PTSD and other conditions.